Business / Finance

RSS

New report on the immunomodulators market outlook to 2016

TNF inhibitors indicated for the treatment of rheumatoid arthritis, psoriasis and inflammatory bowel disease formed the largest share of the market, according to a new report available on companiesandmarkets.com. The top three products: Remicade, Humira and Enbrel accounted for 40.1% of the market in 2010.

23 Aug 2011

GE launches new release of healthcare revenue cycle management solution

GE Healthcare, a leading provider of healthcare information technology, today launched Centricity Business 5.0, the next-generation revenue cycle management solution for hospital networks, academic medical centers, large practices and physician billing groups.

23 Aug 2011

HTA opens new office in Indianapolis

Healthcare Trust of America, Inc. ("HTA"), a fully integrated, self-administered, self-managed real estate investment trust, is proud to announce that effective August 1, 2011, HTA opened a new office in Indianapolis.

23 Aug 2011

PracticeMax acquires American Billing Services of Portland

PracticeMax, a provider of revenue cycle management and software services, today announced it has acquired American Billing Services (ABS) of Portland, Oregon, expanding the operations and geographical footprint of PracticeMax in the northwestern United States.

23 Aug 2011

QHR second quarter revenue increases 3% to $5,230,505

QHR Technologies Inc. a leader in the Canadian Healthcare Information Technology sector, is pleased to announce today the release of its second quarter financial statements for June 30, 2011 and continuing progress in its growth targets.

23 Aug 2011

CHL completes $18.4-million Series B financing round

Cleveland HeartLab Inc. (CHL), a leading specialty clinical laboratory and disease management company, today announced the completion of an $18.4-million Series B financing round.

23 Aug 2011

HemaCare second quarter revenue increases to $4.2 million

HemaCare Corporation announced today that the Company generated 2011 second quarter revenue of $4.2 million from continuing operations and a net loss of $252,000, or $(0.03)/share, including net income from discontinued operations of $180,000 compared to second quarter 2010 revenue from continuing operations of $3.9 million and net income of $223,000, or $.02/share, including net income of $843,000 from discontinued operations.

23 Aug 2011

MME, WNDM sign major agreement to distribute CellerateRX

Wound Management Technologies, Inc., a leader in advanced wound care solutions, today announced a major distribution deal with Marketing Media Enterprises, LLC (MME), an Orlando Florida medical products distributor serving the direct-to-consumer and military market.

23 Aug 2011

IVAX Diagnostics net revenues decrease 0.4% to $4,375,000 for quarter ended June 30, 2011

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended June 30, 2011.

23 Aug 2011

Vention Medical announces acquisition of Ansamed

Vention Medical, a leading full-service medical device outsourcing company, announced today its acquisition of Ansamed, Ireland's premier provider of advanced medical tubing solutions, including multilayer, co-extrusion and multi-lumen extrusion capabilities, and catheter design, development and manufacturing services.

23 Aug 2011

Drug co. executive gives pharma a sunny forecast

Severin Schwan thinks the skeptics are wrong. Those who shun the pharmaceutical sector for its lack of prospects don't understand the potential created by a rapidly growing understanding of genetics and molecular biology, and the new drugs that will follow. ... the chief executive of Roche Holding AG, the world's seventh-largest drug firm by sales, is an informed optimist.

22 Aug 2011

Nightingale receives ISO 13485:2003 certification for EMR and associated services

Nightingale Informatix Corporation, a developer and provider of web-hosted Electronic Medical Record (EMR) software and associated services, announced today that it has received ISO 13485:2003 certification.

22 Aug 2011

UHC report outlines ways to combat high cost of care through supply chain purchasing process

While health care reform looks at ways to combat the high cost of care, many of the nation's top hospitals have already found ways to eliminate unnecessary costs through the supply chain purchasing process.

20 Aug 2011

SVEFCU approves a merger with McGraw-Hill Federal Credit Union

Following a vote of its membership on August 18, St. Vincent's Employees Federal Credit Union (SVEFCU) has approved a merger with McGraw-Hill Federal Credit Union.

20 Aug 2011

HDS discusses market opportunity linked with carbon sequestration technologies

HDS International Corp., a provider of industrial ocean-based biomass production and other high-value eco-sustainability solutions, today discussed the market opportunity associated with its carbon sequestration technologies.

20 Aug 2011

Duke LifePoint to acquire Person Memorial Hospital

Duke LifePoint Healthcare, a joint venture of Duke University Health System, Inc. and LifePoint Hospitals, and the Person Memorial Hospital (PMH) Board of Trustees today announced that they have signed a definitive agreement for Duke LifePoint to acquire PMH.

20 Aug 2011

Tibet Pharmaceuticals second quarter revenue increases 12% to $8.7 million

Tibet Pharmaceuticals, Inc., an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, today announced the availability of the transcript for its second quarter 2011 earnings conference call, held on August 16th.

20 Aug 2011

Cannabis Science enters distribution agreement with PVM for marijuana dispensing machines

Cannabis Science, Inc., a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that Cannabis Science has entered into an exclusive distribution Agreement with Prescription Vending Machines Inc. ("PVM") and contracted with PVM's principal Vincent Mehdizadeh to provide industry specific consulting and advisory services to Cannabis Science.

19 Aug 2011

DiaGenic reports operating revenue of NOK 1,151 thousand for second quarter 2011

DiaGenic: Important milestones achieved. DiaGenic's collaboration with Pfizer is the first collaboration between a diagnostics company and the market leader for Alzheimer's therapeutics that aims to identify blood based diagnostic tools that can detect early Alzheimer's disease, before the disease is clinically overt, or accessible to other either more invasive and costly or less precise diagnostic exploration.

19 Aug 2011

Furiex enters loan agreement with MidCap Financial, Silicon Valley Bank

Furiex Pharmaceuticals, Inc. announced today it has entered into a loan agreement with MidCap Financial and Silicon Valley Bank to provide up to $15.0 million in capital through a secured term loan. Furiex intends to use the proceeds to support research and development for its clinical stage compounds JNJ-Q2, MuDelta and PPD10558.

19 Aug 2011